Table 2

Results of the genome-wide association meta-analysis (unadjusted, showing those SNPs having p<10−5).

MAFImputation quality*
SNPChrGeneNRS1RS3TUKFHSGARPRS1RS3TUKFHSGARPEff all βSEp Value
rs170346873NA44290.090.10.050.08NA0.920.930.880.82NAC0.230.0381.82E-09
rs21876896NA44570.080.070.060.09NA0.980.990.950.93NAC0.230.0412.72E-08
rs77672776NA44570.080.070.060.09NA0.980.990.950.93NAA0.230.0412.81E-08
rs9268496PARK239390.310.32NA0.310.230.980.99NA0.995.04C−0.130.0243.25E-08
rs77446666NA44660.10.090.060.1NA0.9910.970.96NAC0.20.0375.58E-08
rs119690026NA44660.10.090.060.1NA0.9910.970.96NAA0.20.0375.59E-08
rs64576906NA44640.10.090.070.11NA0.9810.960.97NAA0.190.0369.36E-08
rs10292966NA44640.10.090.070.11NA0.9810.960.97NAC0.190.0369.39E-08
rs69360046NA44620.10.090.070.11NA0.9810.960.97NAC0.190.0361.04E-07
rs37499826NA44580.10.090.060.1NA0.9910.960.96NAA0.190.0371.46E-07
rs94693006NA44820.10.090.070.1NA0.9910.920.96NAA0.190.0371.47E-07
rs102148866NA44790.10.090.070.11NA0.9810.920.97NAA0.190.0362.32E-07
rs100462576NA44610.10.090.080.11NA0.9810.960.97NAA0.190.0373.22E-07
rs48751028NA46080.260.260.270.250.290.990.990.950.9197.65A−0.120.0243.61E-07
rs30194496PARK246360.320.320.310.310.280.980.980.980.9997.18A−0.120.0233.68E-07
rs10292956NA37470.10.09NA0.11NA0.981NA0.97NAC0.190.0384.58E-07
rs930195113GPC643970.040.040.030.05NA0.960.970.740.78NAC−0.260.0549.47E-07
rs789669110PFKP46520.10.10.090.130.070.9910.960.6797.61C0.170.0352.02E-06
rs660202410PFKP46730.10.10.090.130.070.9910.980.6797.62A0.170.0352.20E-06
rs18841586PARK244910.310.320.310.31NA0.980.990.990.91NAC−0.110.0233.56E-06
rs1099846610NA44460.010.010.010.02NA0.750.970.730.51NAA−0.530.1143.59E-06
rs1713217510PFKP46590.10.10.090.130.070.980.990.970.6397.13C0.160.0363.73E-06
rs198148316PIGQ39390.420.43NA0.420.470.990.98NA0.4499.64A0.110.0233.75E-06
rs11540538NA46390.170.170.180.160.20.9910.960.8996.17C−0.130.0283.99E-06
rs7376316PARK243030.280.290.230.28NA0.920.910.890.83NAA−0.110.0254.32E-06
rs248499010NA44290.010.0100.02NA0.560.820.470.93NAC0.680.1484.39E-06
rs125030710NA44150.010.0100.02NA0.560.820.450.94NAA0.680.1484.39E-06
rs720443916RAB40C39390.420.43NA0.430.470.970.98NA0.4397.37C0.110.0234.43E-06
rs480266619MYH1440940.270.270.180.27NA0.70.740.760.64NAA−0.130.0294.55E-06
rs248499210NA44400.010.0100.02NA0.560.820.480.93NAC0.680.1494.81E-06
rs94882386NA44640.040.030.020.03NA0.870.880.870.97NAA−0.280.0615.17E-06
rs76301416RAB40C39390.420.43NA0.430.470.980.99NA0.4299.4C0.10.0235.43E-06
rs12058636NA39390.060.06NA0.060.070.991NA0.9998.23G0.210.0475.64E-06
rs119186543ARL8B43100.270.270.290.27NA0.970.980.90.99NAC−0.110.0247.10E-06
rs488108510PFKP44900.10.10.10.13NA110.990.67NAA0.160.0367.44E-06
rs26571958NA43160.220.210.180.21NA0.850.850.870.74NAA−0.130.0287.54E-06
rs117546416NA44780.030.030.020.04NA0.930.950.911NAC0.290.0647.84E-06
rs1280587511NA46740.420.410.420.430.41111198.12A0.090.0218.51E-06
rs9802388NA44910.30.290.310.29NA1111NAA−0.10.0239.11E-06
rs710300411NA46670.420.410.420.430.41110.99197.09C0.090.0219.20E-06
rs455485911NA46740.420.410.420.430.41111198.12G0.090.0219.24E-06
rs711841211NA46690.420.410.420.430.41110.99197.09A0.090.0219.37E-06
rs201756716NA46830.420.430.420.420.470.99110.45100C0.10.0219.38E-06
rs71092416PIGQ46830.420.430.420.420.471110.4599.64C0.090.0219.93E-06
  • *r2 from MACH for RS1, RS3, FHS and GARP; information score from IMPUTE for TUK.

  • Studies contributing data are denoted.

  • SNP, single nucleiotide polymorphism; Chr, chromosome; N, number of subjects studied; MAF, minor allele frequency; RS1, Rotterdam study cohort 1; RS3, Rotterdam study cohort 3; TUK, TwinsUK; FHS, Framingham Heart Study; GARP, Genetics of OsteoArthrosis and Progression study; Eff all, effect allele; β, effect size; SE, SE of β.